Sweetums Sucrose Solution (Clinical Innovations) – Product Defect (2022)
Class II: A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Class II recall indicates potential for temporary health effects.
This AI-generated summary is provided for general informational purposes only and is derived from publicly available recall notices. It supplements but does not replace official agency classifications or safety instructions.
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
Sweetums 24% sucrose solution with preservative. Vials containing 1ml or 2ml of 24% sucrose in purified water. Product is administered by drop using vials and tip allows controlled administration directly to tongue or buccal surface. Product is only used in the hospital setting including the NICU. -VPSU15032250, 1mL vial, bagged qty 250
Brand
Clinical Innovations, LLC
Lot Codes / Batch Numbers
VPSU15032250 21029a 03/31/2023 VPSU15032250 21031a 03/31/2023
Products Sold
VPSU15032250 21029a 03/31/2023 VPSU15032250 21031a 03/31/2023
Clinical Innovations, LLC is recalling Sweetums 24% sucrose solution with preservative. Vials containing 1ml or 2ml of 24% sucrose in purif due to Firm received complaints of leaking, black liquid, and black particulates in the product vials.. This is a Class I recall, indicating a high risk of serious health consequences. Based on FDA enforcement report.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
Firm received complaints of leaking, black liquid, and black particulates in the product vials.
Recommended Action
Per FDA guidance
Consumers should stop using the product and contact the recalling firm or return it to the place of purchase.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticePage updated: Jan 6, 2026